Sitaxsentan Sodium CAS 210421-74-2

Khoom Piav Qhia

Khoom npe: Sitaxsentan sodium CAS 210421-74-2

Txhais:

Thelin;

Sitax;

Sitaxentan sodium;

sodium, (4-chloro-3-methyl-1,2-oxazol-5-yl) - [2- [2- (6-methyl-1,3-benzodioxol-5-yl) acetyl] thiophen-3-yl ] sulfonylazanide;

Tshuaj& Lub cev nqaij daim tawv

Zog: cov hmoov dawb dawb dawb-dawb

Ntsuas: ≥98.0%

Dej Solubility: H2O: soluble10mg / mL (cov dej ntshiab)

Xaiv endothelin A (ETA) receptor antagonist. Antihypertensive. Siv rau kev kho mob ntawm lub plawv tsis ua haujlwm.

Sitaxentan sodium, belongs rau thesulfonamide chav kawm ntawm endothelin receptor antagonists.Although nws muaj 6,000-fold xaiv rau ETA receptor, kev soj ntsuam sim tsis tau qhia ntau dua kev ua tau zoo ntawm bosentan. Txawm li cas los xij, nws muaj ntau daim siab ua kom lub siab toxicitythan bosentan. Lub chaw tsim khoom yog sim ua kom tau raws li cov txiaj ntsig tau teev tseg los ntawm FDA, uas yuav tsum tau ntsib ua ntej kev pom zoo ntawm sitaxsentan raws li tus neeg sawv cev yuav kho.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: sitaxsentan sodium cas 210421-74-2, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: 2 - [[2-Ethoxy-4- (4-hydroxy-1-piperidinyl) phenyl] amino] -5,11-dihydro-5,11-dimethyl-6H-pyrimido [4,5-b] [1,4 ] benzodiazepin-6-ib CAS 1234480-50-2
• Tom ntej: 3-Chloro-5,6-dihydro-1- (4-nitrophenyl) -2 (1H) -pyridinone CAS 536760-29-9